Biotechnology
The FTC cleared Amgen’s $27.8 billion Horizon buyout — here’s what it means for other massive pharma deals
Robert Galbraith | Reuters The Federal Trade Commission last week allowed Amgen to move forward with its $27.8 billion acquisition of Horizon Therapeutics under a settlement agreement – a move that could have ramifications for a string of other pharmaceutical industry buyouts. Some Wall Street analysts said the FTC’s decision allows the sector to breathe […]
Read More
Illumina names new CEO months after Icahn proxy fight over Grail deal
A building on the campus at the world headquarters of Illumina is shown in San Diego, California, Sept. 1, 2021. Mike Blake | Reuters Illumina‘s board on Tuesday named Jacob Thaysen the DNA sequencing company’s new CEO as it tries to rebound from a grinding dispute over its acquisition of cancer test developer Grail. Thaysen, […]
Read More
Can you use expired Covid tests? What to know as cases rise, new variants emerge
In this photo illustration, Abbott’s at-home covid-19 rapid test kits are seen on display in Orlando. Paul Hennessy | LightRocket | Getty Images As Covid cases surge again in the U.S., Americans are digging out unused at-home tests that they stashed earlier on in the pandemic. Many of those tests may have passed their expiration […]
Read More
Novo Nordisk’s Wegovy weight loss drug launches in the Uk
Offers of the weight-loss drug Wegovy from the pharmaceutical business Novo Nordisk lie on the income counter in a Danish pharmacy. Stefan Trumpf | Photo Alliance | Getty Photographs Novo Nordisk introduced its Wegovy pounds decline injection in the U.K. on Monday, advancing the drug’s rollout in Europe regardless of ongoing source constraints. The Danish […]
Read More
Judge withdraws from Medicare drug price case after stock ownership is revealed
Ohio Governor Mike DeWine, right, shakes hands with Judge Thomas Rose of the U.S. District Court Southern District of Ohio after taking his oath of office, Monday, Jan. 14, 2019, in Cedarville, Ohio. John Minchillo | AP A federal judge on Friday withdrew from a case that could block Medicare from negotiating over drug prices, […]
Read More
When to wear masks as Covid cases rise, new variants emerge in the U.S.
Michael Nason, 29, left, and Donna Nason, 25, right, both of Bakersfield are wearing a face mask in Union Station on Thursday, Aug. 31, 2023, in Los Angeles, CA. COVID-19 making a comeback in California. Francine Orr | Los Angeles Times | Getty Images An uptick in Covid cases and hospitalizations in the U.S., and […]
Read More
FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition
The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images The Federal Trade Commission on Friday said it has reached a deal with drug giant Amgen to allow the company’s $27.8 billion purchase of Horizon Therapeutics to move forward. The FTC filed a lawsuit […]
Read More
Ozempic could be the next target of Medicare drug price negotiations – here’s why
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. George Frey | Reuters Ozempic, the blockbuster diabetes treatment from Novo Nordisk, could be next in line for price negotiations between manufacturers and Medicare. […]
Read More
HHS calls for easing restrictions on marijuana, sending cannabis stocks higher
James Romano trims flower while working in CommCans processing facility in Medway, MA on Oct. 27, 2021. Beneath the trimmed flower is a tray collecting shake, cannabis flower that has naturally broken down through handling. Shake can be used in CommCans pre-rolled joints or made into edibles. Erin Clark | Boston Globe | Getty Images […]
Read More
Medicare wants to cut the price on an Eli Lilly drug. What it means for LLY shares
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval. AJ Mast | Bloomberg | Getty […]
Read More